Loading...

LIMN LIMINATUS PHARMA INC Business Restructuring 8-K Filing

LMNT

LMN

LIMINATUS PHARMA INC

(LIMN)

2025 8-K

Bylaw Amendment

Stock Offering Details

Settlement Agreement

Delisting Notice

Nasdaq Non-Compliance

Nasdaq Non-Compliance

Research Update

Investor Meetings

Non-Compliance Notification

Merger of Equals

Merger of Equals

External Links:

On July 16, 2025, Liminatus Pharma, Inc. agreed to issue 350,000 shares of common stock in exchange for the cancellation of 1,000,000 warrants held by Alta Partners, LLC. This exchange has not been registered under the Securities Act.

AI Assistant

LIMINATUS PHARMA INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.